Mergers, Philanthropic Excellence and Cost-Effective Technologies - Research Report on Applied Materials, Cree, ASML, Himax and Synopsys

NEW YORK, June 17, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Wall Street Reports announced new research reports highlighting Applied Materials Inc. (NASDAQ: AMAT), Cree, Inc. (NASDAQ: CREE), ASML Holding NV (NASDAQ: ASML), Himax Technologies, Inc. (NASDAQ: HIMX) and Synopsys Inc. (NASDAQ: SNPS). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Applied Materials Inc. Research Report

On June 7, 2013, Applied Materials Inc. (Applied Materials) announced that the partnership between Applied Materials foundation and the California-based nonprofit organization, Partners in School Innovation, was selected to be recognized by the Committee for Encouraging Corporate Philanthropy with its 13th Annual Excellence Award. The Award honors a partnership that embodies three pillars of excellence: Innovation, Dedication to measurement and Executive Leadership. At the recent CECP Summit in New York City, Partners' Chief Executive Officer, Derek Mitchell accepted the Award thanking the Applied Materials Foundation for its collaboration, its commitment to encouraging rigor in program implementation, and its ability to ask tough questions that lead to progress that benefits students and teachers in Silicon Valley. The Full Research Report on Applied Materials Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at [http://www.wsreports.com/r/full_research_report/2018_AMAT]

--

Cree, Inc. Research Report

On June 4, 2013, Cree, Inc. (Cree) introduced a 102 lumen-per-watt linear LED upgrade kit to replace fluorescent lamps. According to the Company, the inventive, new Cree UR Series LED Upgrade Kit can deliver payback in less than two years and makes upgrading to LED lighting simple and easy. The UR series is easy to install, saves over 50% in energy, provides better light, and lasts up to twice as long as the standard 32-W fluorescent lamps it replaces. "Fluorescent technology has reached the end of its useful life," said Greg Merritt, Vice President, Lighting at Cree. "The UR Series is an ideal solution for applications where building owners prefer to retain existing lighting fixtures, including hospitals where retrofit construction can negatively impact the environment. Thanks to the design of the UR Series, our customers now have an LED option that is cost-effective and easy to install and use when retrofitting their existing linear fixtures." The Full Research Report on Cree, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at [http://www.wsreports.com/r/full_research_report/f2aa_CREE]

--

ASML Holding NV Research Report

On May 30, 2013, ASML Holding NV (ASML) and Cymer Inc. (Cymer) jointly announced that they have completed the previously announced merger pursuant to which ASML has acquired Cymer. As a result of the merger, each share of Cymer common stock outstanding immediately prior to the completion of the merger was converted into the right to receive $20.00 in cash plus 1.15 ASML ordinary shares. The Company stated that ASML's share capital will increase by approximately 36.5 million shares as a result of the merger. The Full Research Report on ASML Holding NV - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at [http://www.wsreports.com/r/full_research_report/265b_ASML]

--

Himax Technologies, Inc. Research Report

On June 10, 2013, Himax Technologies, Inc. (Himax) announced the commencement of an offering of 22.1 million American Depositary Shares (ADSs), each representing two ordinary shares of the Company, by selling shareholder Innolux Corporation (Innolux). The Company will not receive any proceeds from the sale of the ADSs by Innolux, and the sale will not result in dilution of the Company's outstanding shares. Innolux intends to grant the underwriters an option to purchase up to 3.3 million additional ADSs solely to cover over-allotments, if any. The Full Research Report on Himax Technologies, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at [http://www.wsreports.com/r/full_research_report/732a_HIMX]

--

Synopsys Inc. Research Report

On June 11, 2013, Synopsys Inc. (Synopsys) unveiled a new, innovative test technology to further reduce the cost of testing silicon devices by delivering upto 3 times higher test compression and minimizing the time required to test each silicon die. "Our initial review of Synopsys' new test technology shows it can achieve up to three times higher compression compared to existing solutions," said Roberto Mattiuzzo, SoC test and diagnosis manager at STMicroelectronics' Central CAD and Design Solutions. "The technology can be deployed on a variety of design styles with any number of test pins and supports high-speed test clocks. It is well aligned with our ever-increasing requirements to lower the cost and raise the quality of test for our silicon products using our current and ready-for-production fabrication process." The Full Research Report on Synopsys Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at [http://www.wsreports.com/r/full_research_report/8cbc_SNPS]

----

EDITOR NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
5. For any urgent concerns or inquires, please contact us at [email protected].
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

SOURCE Wall Street Reports